NextCure, Inc. (NXTC)

NextCure Statistics

Total Valuation

NextCure has a market cap or net worth of $37.06 million. The enterprise value is $398,868.

Market Cap	37.06M
Enterprise Value	398,868

Important Dates

The last earnings date was Thursday, March 5, 2026, after market close.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

NextCure has 3.56 million shares outstanding. The number of shares has increased by 21.97% in one year.

Current Share Class	3.56M
Shares Outstanding	3.56M
Shares Change (YoY)	+21.97%
Shares Change (QoQ)	+48.77%
Owned by Insiders (%)	1.24%
Owned by Institutions (%)	27.10%
Float	2.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.04
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.14, with a Debt / Equity ratio of 0.15.

Current Ratio	4.14
Quick Ratio	3.97
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -111.23% and return on invested capital (ROIC) is -64.58%.

Return on Equity (ROE)	-111.23%
Return on Assets (ROA)	-54.96%
Return on Invested Capital (ROIC)	-64.58%
Return on Capital Employed (ROCE)	-145.43%
Weighted Average Cost of Capital (WACC)	11.23%
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.19% in the last 52 weeks. The beta is 1.55, so NextCure's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	+52.19%
50-Day Moving Average	12.34
200-Day Moving Average	8.93
Relative Strength Index (RSI)	36.51
Average Volume (20 Days)	36,907

Short Selling Information

The latest short interest is 56,033, so 1.57% of the outstanding shares have been sold short.

Short Interest	56,033
Short Previous Month	61,725
Short % of Shares Out	1.57%
Short % of Float	2.51%
Short Ratio (days to cover)	1.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-57.62M
Pretax Income	-55.84M
Net Income	-55.84M
EBITDA	-55.43M
EBIT	-57.62M
Earnings Per Share (EPS)	-$19.65

Balance Sheet

The company has $41.82 million in cash and $5.15 million in debt, with a net cash position of $36.67 million or $10.30 per share.

Cash & Cash Equivalents	41.82M
Total Debt	5.15M
Net Cash	36.67M
Net Cash Per Share	$10.30
Equity (Book Value)	34.94M
Book Value Per Share	9.97
Working Capital	33.18M

Cash Flow

Operating Cash Flow	-49.61M
Capital Expenditures	n/a
Depreciation & Amortization	2.19M
Net Borrowing	n/a
Free Cash Flow	-49.61M
FCF Per Share	-$13.93

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NextCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.97%
Shareholder Yield	-21.97%
Earnings Yield	-150.67%
FCF Yield	-133.86%

Analyst Forecast

The average price target for NextCure is $23.00, which is 120.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.00
Price Target Difference	120.94%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-59.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 14, 2025. It was a reverse split with a ratio of 1:12.

Last Split Date	Jul 14, 2025
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	1